NetworkNewsBreaks – Cannabis Global, Inc. (MCTC)
Post# of 112
Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today provided an update for current and prospective shareholders as it continues to make strong progress on its “Project Varin” initiative. Project Varin, designed to produce ultra-highly bioavailable exotic cannabinoids, launched earlier this year and, to date, has produced new cannabinoid production techniques, unique time-released polymeric nanoparticles and two novel patent filings. Cannabis Global is now implementing a program to produce commercially viable quantities for use in its own products to be released later this month. “While THC-V is found in very small quantities within the cannabis plant, extraction, isolation and purification is currently problematic and unreliable,” Cannabis Global CEO Arman Tabatabaei said in the news release. “For this reason, we have expanded our research and development programs to include ultra-pure manufactured THC-V. We expect our new THC-V products to not only be the first to market, but to also establish leadership relative to quality and purity with zero heavy metals, solvent residues, plant impurities and no chance of cannabinoid microbial and mold proliferation. Other manufacturers need to mitigate these issues, but with our technology, these simply cannot be issues as we completely avoid the processing steps where such impurities are introduced.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer